Logo Surge

It’s time to decrypt the immune system to drive precision health

Our partners

Technology & science

PreCyte, a unique immunological fingerprinting technology

The end result of 10 years of research, PreCyte is a breakthrough technology that integrates the high-resolution exploration of the human immune system with the identification of actionable predictive information to optimize preventive strategies, and develop new treatments or medical devices.

products & services

The PreCyte technology brings the capacity to develop products and services that empower the healthcare team.

PreCyte surgical provides an accurate prediction of surgical complications to aid surgical decision-making and enable the optimization of individual patient’s’ perioperative care pathway

Press & Scientific publications

Nos articles

Press Release
Surge announces closing of a €7.5 million fundraising round to decrypt the immune system and transform precision medicine
Press Release
Surge et Arkhn remportent le Challenge AI For Health de la Région Île-de-France grâce au projet PRISMA, une approche innovante pour anticiper les risques post-opératoires avec l’Hôpital Foch
Non classé
Surge voted Start-up of the year at the French-American Business Awards • FABA 2023
Who we are
Founded in Silicon Valley, Surge is led by a team of six talented individuals from Stanford, Harvard, Sorbonne, and Ecole Polytechnique.
Logo Surge